Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.
about
Transfer of microRNAs by embryonic stem cell microvesiclesFunctional Role of Milk Fat Globule-Epidermal Growth Factor VIII in Macrophage-Mediated Inflammatory Responses and Inflammatory/Autoimmune DiseasesDynamics of circulating microparticles in chronic kidney disease and transplantation: Is it really reliable marker?Microparticles That Form Immune Complexes as Modulatory Structures in Autoimmune ResponsesMolecular characterisation of plasma membrane-derived vesiclesMilk fat globule epidermal growth factor VIII signaling in arterial wall remodelingGeneration and biological activities of oxidized phospholipidsAssessment of endothelial dysfunction in childhood obesity and clinical use.Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing.Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification.Membrane Ballooning in Aggregated Platelets is Synchronised and Mediates a Surge in Microvesiculation.PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferationA standardized exercise intervention differentially affects premenopausal and postmenopausal African-American women.The Methods of Choice for Extracellular Vesicles (EVs) Characterization.Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation.Exosomes in bodily fluids are a highly stable resource of disease biomarkersAcetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease.The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases.Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea.Circulating endothelial microparticles in diabetes mellitusMicroRNAs as lung cancer biomarkersEarly posttransplant changes in circulating endothelial microparticles in patients with kidney transplantation.Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection.Endothelial microparticles interact with and support the proliferation of T cells.Circulating microparticles and endogenous estrogen in newly menopausal women.Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic populationAggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women.Microparticle-mediated transfer of the viral receptors CAR and CD46, and the CFTR channel in a CHO cell model confers new functions to target cells.Transfer of human hepatocyte growth factor reduces inflammation and prevents pulmonary arterial remodeling in monocrotaline-induced.Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes.Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding.Vascular inflammation and endothelial dysfunction in experimental hypertension.Endothelial microparticles: sophisticated vesicles modulating vascular function.Isolation and phenotypic characteristics of microparticles in acute respiratory distress syndrome.Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control.Administration of microparticles from blood of the lipopolysaccharide-treated rats serves to induce pathologic changes of acute respiratory distress syndromeProfiling of circulating microRNAs: from single biomarkers to re-wired networksShear stress-induced mitochondrial biogenesis decreases the release of microparticles from endothelial cells.Microparticle-Induced Activation of the Vascular Endothelium Requires Caveolin-1/Caveolae.
P2860
Q21143855-BA51F1D4-760E-4683-9112-E20AB895CAC6Q26739546-A7F80144-9863-4A47-B345-0825D18F733AQ26771389-ACB7A2CD-ED7A-4020-8A5B-0EF47383F2FCQ26795583-755D5263-322A-4AE5-A991-5D140E5B8C7AQ26799753-F00072C8-0A1F-4471-A779-BD7901277CFEQ27013859-F9CB7063-9820-4E7C-85E2-0F1CFEF14D6FQ28389691-B5DC6D3B-2D84-40F8-A156-F9173FC50148Q30430798-7C47F5B6-26A1-467B-B03B-A8FF39693E9DQ30433778-89129015-868C-4440-825B-D7234227170BQ30664287-4B08EB01-C206-4C27-877F-40323F97FF70Q30854772-A5640FA1-6A0D-47B1-9522-CC57903A7158Q33400120-D398D2D1-A1B9-4994-A1B2-C06A55366EEBQ33518352-BB376377-33D9-4301-BA9A-B09048F7AFA5Q33579061-BB1992CB-226F-4479-9098-E0798C66D579Q33838541-469E2F5B-4BCF-405D-9C8A-C50C27CCBA2FQ33857901-872AEABB-1EE2-495C-B117-152FB8EC3D6BQ33885679-BE174E48-3911-45E4-9D0E-40572F9C04E1Q33888658-80C84D21-C016-4536-9FFB-060F9A4169FBQ33916623-A8328D00-BD9F-4121-9D49-9B0DBDBECB39Q33953737-2AAB3D81-EBD1-40BE-BED5-AAD86D4CE144Q33996570-0A01DEBC-56D1-409A-B2B0-A3D6467942C4Q34031213-B3953668-548F-4561-B529-D0EFB75A0E82Q34076305-09F8FBEE-59AA-42FF-A23F-F3042FCF929AQ34167920-9B6F5BE7-23FE-4C77-8076-37CDF731EA87Q34218647-8AD5A6E3-F8C4-47F5-AEDE-1C838C8AAD05Q34476755-666B9296-6F71-4EE0-A121-36B7D9A76D0CQ34488533-893137D8-5406-4CF0-835C-7B782DD7135BQ34491825-5E730A5A-9E4A-4457-8170-26AB4EC79A32Q34533653-4C1FB6F1-893D-493D-BE06-B06295EC6634Q35038418-8BC34822-8EDB-4E58-8FDB-9471F705DA58Q35089453-10A9C6A3-ACF8-4945-9961-8E871A2A2427Q35207653-EFAF3227-363D-4EB5-BB4F-04852CFCC56AQ35207893-E6BC3894-C226-4A5A-AFA8-ACF2BF2E7B6FQ35624092-7AC473D0-ADB1-4674-BD17-48DA3EF2346DQ35631232-EABE3D9A-FBFC-4551-996D-00E8DC2E6FB3Q35633008-E68FC7DD-97E6-4B12-981C-8BD5899775A3Q35668012-C3E255E8-1B78-4D14-A28F-43BE360F8546Q35792720-6B02EDD4-7AD7-4138-A568-8C841AB45675Q35916758-89E6DDEF-3B6F-4A9C-AF6D-56D6846D41ABQ35927423-4744EB97-56A4-413E-B85B-560F010414C8
P2860
Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Circulating microparticles: a ...... erosclerotic vascular disease.
@ast
Circulating microparticles: a ...... erosclerotic vascular disease.
@en
type
label
Circulating microparticles: a ...... erosclerotic vascular disease.
@ast
Circulating microparticles: a ...... erosclerotic vascular disease.
@en
prefLabel
Circulating microparticles: a ...... erosclerotic vascular disease.
@ast
Circulating microparticles: a ...... erosclerotic vascular disease.
@en
P1433
P1476
Circulating microparticles: a ...... erosclerotic vascular disease.
@en
P2093
Chantal M Boulanger
Nicolas Amabile
P304
P356
10.1161/01.HYP.0000231507.00962.B5
P407
P50
P577
2006-06-26T00:00:00Z